Suppr超能文献

尿毒症患者对乙酰氨基酚的血液透析

Hemodialysis of acetaminophen in uremic patients.

作者信息

Marbury T C, Wang L H, Lee C S

出版信息

Int J Artif Organs. 1980 Sep;3(5):263-6.

PMID:7461859
Abstract

The effect of the artificial kidney on the removal of acetaminophen was investigated in 6 chronic hemodialysis patients. Acetaminophen, 650 mg, was given orally 2 hrs prior to hemodialysis. Plasma and dialysate samples were collected periodically over 3 hours and analyzed by HPLC for acetaminophen content. Dialysis clearance was calculated by Arterial-venous difference and simultaneous dialysate measurement. The extraction efficiency of the hollow-fiber dialyzers averaged 47.5%. The mean dialysis clearance of 112 ml/min measured with blood as the body fluid of reference was confirmed by calculation of clearance using dialysate measurement. A mean of 70.5 mg of acetaminophen for 11% of the administered dose was removed during the 3 hour dialysis period. The beta phase had a mean half-life of 1.6 hours in our patients on hemodialysis compared with 2.0 hours reported for both normal patients and uremic patients. Despite the favorable extraction ratio and dialyzer clearance, the artificial kidney is not very effective in competing with the liver for removal of the parent compound acetaminophen because of the drug's short half-life and rapid hepatic metabolism. Hence, the chronic hemodialysis patient may not need a dosage adjustment during or following hemodialysis.

摘要

在6例慢性血液透析患者中研究了人工肾对乙酰氨基酚清除的效果。在血液透析前2小时口服650毫克乙酰氨基酚。在3小时内定期采集血浆和透析液样本,并通过高效液相色谱法分析乙酰氨基酚含量。通过动静脉差值和同步透析液测量计算透析清除率。中空纤维透析器的提取效率平均为47.5%。以血液作为参考体液测得的平均透析清除率为112毫升/分钟,通过透析液测量计算清除率得到了证实。在3小时的透析期间,平均清除了70.5毫克乙酰氨基酚,占给药剂量的11%。在我们的血液透析患者中,β期的平均半衰期为1.6小时,而正常患者和尿毒症患者报告的半衰期为2.0小时。尽管提取率和透析器清除率良好,但由于药物半衰期短且肝脏代谢迅速,人工肾在与肝脏竞争清除母体化合物乙酰氨基酚方面并不是很有效。因此,慢性血液透析患者在透析期间或透析后可能不需要调整剂量。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验